These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8983763)

  • 1. [The treatment of vibration-induced disease with calcium-channel blockers].
    Kostiuk IF; Kapustnik VA
    Lik Sprava; 1995; (9-12):157-60. PubMed ID: 8983763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of local vibration on central and cerebral hemodynamics].
    Sova SH
    Lik Sprava; 1999; (3):68-71. PubMed ID: 10474940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the ion-transport processes in the erythrocytes in vibration-induced disease from exposure to local vibration].
    Kostiuk IF; Kapustnik VA; Belous AM
    Lik Sprava; 1994; (9-12):121-3. PubMed ID: 7604548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of vibration-induced disease with corinfar].
    Sukharevskaia TM; Loseva MI; Pakhomova AM; Bolotnova TV
    Gig Tr Prof Zabol; 1989; (4):37-9. PubMed ID: 2744569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium antagonists in arterial hypertension].
    Muiesan G
    G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].
    Sakai M; Ueda K; Nakahara K; Tsuchimochi H; Mutsushita S; Kuramoto K; Murakami M
    Kokyu To Junkan; 1985 Feb; 33(2):159-64. PubMed ID: 4001593
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium channel blockers. New treatment for cardiovascular disease.
    Rossi LP; Antman EM
    Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460
    [No Abstract]   [Full Text] [Related]  

  • 8. [The Berlipril and Retalzem treatment of hypertension patients: the dynamics of the clinico-hemodynamic indices and of the vasodilating humoral factors].
    Koval' SN; Starchenko TG; Gorb IuG; Pen'kova MIu; Khasanova KhD
    Lik Sprava; 1999; (1):113-7. PubMed ID: 10424019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
    Kawanishi DT; Reid CL; Gonzales A; O'Rourke RA; Rahimtoola SH
    Circulation; 1989 Dec; 80(6 Suppl):IV162-70. PubMed ID: 2574640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain function and cerebral and peripheral circulation in vibration-induced disease from exposure to local vibration].
    Lipenetskaia TD; Komleva LM; Nikitina LS
    Gig Tr Prof Zabol; 1988 Jul; (7):42-4. PubMed ID: 3181781
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of prostaglandins in the development of the vascular disorders in vibration disease].
    Kostiuk IF; Balagova LP
    Gig Tr Prof Zabol; 1989; (12):53-5. PubMed ID: 2628226
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of vibration on changes in S100B protein content of peripheral blood in miners].
    Kir'iakov VA; Oshkoderov OA; Pavlovskaia NA; Antoshina LI
    Med Tr Prom Ekol; 2014; (8):26-9. PubMed ID: 25549456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in neuromuscular excitability in vibration disease].
    Ian'shina EN; Liubchenko PN; Ian'shin NP; Ovchinnikov ND; Abakumova LIa
    Fiziol Cheloveka; 2003; 29(6):111-3. PubMed ID: 14730944
    [No Abstract]   [Full Text] [Related]  

  • 14. [Percutaneous laser irradiation of blood in the treatment of hemodynamic disorders in patients with vibration disease].
    Shustov VIa; Trubetskov AD; Kalashnikov RV; Utts SR; Dolgova TA
    Med Tr Prom Ekol; 1996; (3):31-4. PubMed ID: 8705143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioelectric activity of the myocardium and central hemodynamics in patients with vibration disease].
    Liubchenko PN; Kovaleva LI; Gorenkov RV; Alekseeva GA; Ian'shina EN
    Med Tr Prom Ekol; 1996; (12):11-4. PubMed ID: 9081647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of the peripheral and central hemodynamics in vibration disease of miners in Eastern Siberia].
    Kolesov VG; Perminov NKh; Blankova IA; Baldakova VP; Moniak AF
    Gig Tr Prof Zabol; 1985 Oct; (10):25-8. PubMed ID: 4076785
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of antioxidants in treating patients with vibration-induced disease].
    Artamonova VG; Kuskova LV
    Gig Tr Prof Zabol; 1991; (4):18-20. PubMed ID: 1831788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-channel blockers and systemic hypertension.
    Frishman WH; Charlap S; Ocken S; Spivack C
    J Clin Hypertens; 1985 Jun; 1(2):107-22. PubMed ID: 3915318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.